Exosome Diagnostics & Therapeutics Market - Global Forecast 2026-2032

The exosome diagnostics and therapeutics market is rapidly transforming, driven by breakthrough scientific advances and increasing clinical demand for precision, minimally invasive solutions. Industry decision-makers face a dynamic landscape shaped by evolving technologies, supply chain pressures, and shifting regulatory requirements.

Market Snapshot: Exosome Diagnostics & Therapeutics Market

The Exosome Diagnostics & Therapeutics Market grew from USD 219.45 million in 2025 to USD 265.76 million in 2026. It is expected to continue growing at a CAGR of 19.10%, reaching USD 746.33 million by 2032.

Scope & Segmentation

Product Segmentation: Instruments, reagents, kits, software, services, and consulting offerings addressing isolation, biochemical workflows, and data interpretation.
Technology Types: Filtration, immune affinity capture, microfluidics, polymer precipitation, and ultracentrifugation, each providing different benefits for purity, scalability, and throughput.
Source Categories: Breast milk, cerebrospinal fluid, saliva, serum and plasma, and urine, reflecting assay-specific requirements and clinical relevance.
Application Segmentation: Oncology (with an emphasis on breast, colorectal, lung, and prostate cancer), cardiovascular, infectious, and neurodegenerative diseases, prenatal diagnosis, drug delivery, and gene therapy.
End-User Segmentation: Academic institutes, diagnostic laboratories, hospitals, pharmaceutical and biotechnology companies, research labs, and specialized clinics, each with tailored adoption drivers.
Regional Coverage: Americas, Europe Middle East & Africa, Asia-Pacific.

Key Takeaways for Senior Decision-Makers

Integration of advanced isolation technologies and multiomic analytics is central to competitive positioning, shifting the focus from point solutions to interoperable platforms.
Successful commercialization demands collaborative models across academia, clinics, and industry to enhance clinical validation and support regulatory requirements.
Clinical adoption relies on end-to-end workflows that combine validated instruments, reagents, software, and consultative services to ensure reproducibility and interpretability.
Diseases such as cancer and gene therapy represent core applications, requiring workflow standardization and tailored validation to address clinical needs across distinct end users.
Regional market entry strategies must be calibrated to local regulatory policies and manufacturing capacities to optimize scaling and supply resilience.

Tariff Impact and Supply Chain Considerations

Changes in trade measures and import tariffs drive procurement recalibration, prompting dual-sourcing, nearshoring, and longer supplier contracts to manage cost and risk.
Tariffs can challenge cross-border research partnerships, leading to possible delays or contract revisions in multicenter clinical studies and supply chain realignments.
Restructuring supply chains may require new supplier qualification and validation under Good Laboratory Practice, affecting the timeline and regulatory compliance of exosome-based products.
Organizations must integrate global trade risks into strategic planning, balancing cost management with the need for consistent supply and robust evidence-generation efforts.

Methodology & Data Sources

This research applies a transparent, multidisciplinary methodology, combining primary stakeholder interviews across academia, clinical, and industry roles with peer-reviewed literature, regulatory review, and cross-validation against published clinical outcomes. These methods ensure diverse perspectives inform technology selection, operational priorities, and regulatory planning.

Why This Report Matters

Enables senior leaders to align investment and R&D strategies with market dynamics, regulatory planning, and critical technology inflection points.
Facilitates informed commercial decisions by mapping stakeholder needs, emerging partnership models, and regional opportunities.
Equips organizations to proactively address supply chain, regulatory, and collaborative complexities in advancing from data to clinic.

Conclusion

The exosome diagnostics and therapeutics market is advancing from innovation to clinical integration, shaped by technical, regulatory, and commercial realities. Organizations that adopt coordinated, multidisciplinary strategies will optimize productization and clinical adoption across diverse market segments.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Exosome Diagnostics & Therapeutics Market, by Product

8.1. Instruments
8.2. Reagents and Kits
8.3. Software and Services
8.3.1. Consulting Services
8.3.2. Data Analysis

9. Exosome Diagnostics & Therapeutics Market, by Technology

9.1. Filtration
9.2. Immune Affinity Capture
9.3. Microfluidics
9.4. Polymer Precipitation
9.5. Ultracentrifugation

10. Exosome Diagnostics & Therapeutics Market, by Source

10.1. Breast Milk
10.2. Cerebrospinal Fluid
10.3. Saliva
10.4. Serum & Plasma
10.5. Urine

11. Exosome Diagnostics & Therapeutics Market, by Application

11.1. Cancer
11.1.1. Breast Cancer
11.1.2. Colorectal Cancer
11.1.3. Lung Cancer
11.1.4. Prostate Cancer
11.2. Cardiovascular Diseases
11.3. Infectious Diseases
11.4. Neurodegenerative Diseases
11.5. Prenatal Diagnosis
11.6. Therapeutic Applications
11.6.1. Drug Delivery
11.6.2. Gene Therapy

12. Exosome Diagnostics & Therapeutics Market, by End User

12.1. Academic Institutes
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Pharmaceutical and Biotechnologies Companies
12.5. Research Laboratories,
12.6. Specialized Clinics

13. Exosome Diagnostics & Therapeutics Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Exosome Diagnostics & Therapeutics Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Exosome Diagnostics & Therapeutics Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Exosome Diagnostics & Therapeutics Market
17. China Exosome Diagnostics & Therapeutics Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AEGLE Therapeutics
18.6. Aethlon Medical Inc.
18.7. AMS Biotechnology
18.8. Bio-Techne Corporation
18.9. Capital Biosciences, Inc.
18.10. Capricor Therapeutics, Inc.
18.11. Celularity Inc.
18.12. Direct Biologics LLC
18.13. Evox Therapeutics Limited
18.14. ExoCoBio Inc.
18.15. EXOGENUS THERAPEUTICS, S.A.
18.16. Exosome biotech company
18.17. ILIAS Biologics Inc.
18.18. KIMERA LABS
18.19. Lonza Group AG
18.20. Mercy Bioanalytics
18.21. NanoFCM Co., Ltd
18.22. NanoSomiX, Inc.
18.23. NeuroSense Therapeutics Ltd.
18.24. Promega Corporation
18.25. PureTech Health plc
18.26. ReNeuron Group plc
18.27. RION
18.28. Sienna Cancer Diagnostics Ltd
18.29. System Biosciences, LLC

List of Figures

FIGURE 1. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNE AFFINITY CAPTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNE AFFINITY CAPTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNE AFFINITY CAPTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMER PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMER PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMER PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ULTRACENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ULTRACENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ULTRACENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST MILK, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST MILK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST MILK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CEREBROSPINAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CEREBROSPINAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERUM & PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERUM & PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRENATAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRENATAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRENATAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGIES COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGIES COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGIES COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES,, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES,, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES,, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 148. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 149. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 153. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 166. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 167. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 169. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 171. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 185. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 186. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 190. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 191. ASEAN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 194. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 195. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 197. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 199. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 200. GCC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 212. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 213. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 215. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 217. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 218. BRICS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 221. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 222. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 224. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 226. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 227. G7 EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 230. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 231. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 233. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 235. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 236. NATO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 249. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 250. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 252. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2032 (USD MILLION)
TABLE 254. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 255. CHINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Exosome Diagnostics & Therapeutics market report include:

AEGLE Therapeutics
Aethlon Medical Inc.
AMS Biotechnology
Bio-Techne Corporation
Capital Biosciences, Inc.
Capricor Therapeutics, Inc.
Celularity Inc.
Direct Biologics LLC
Evox Therapeutics Limited
ExoCoBio Inc.
EXOGENUS THERAPEUTICS, S.A.
Exosome biotech company
ILIAS Biologics Inc.
KIMERA LABS
Lonza Group AG
Mercy Bioanalytics
NanoFCM Co., Ltd
NanoSomiX, Inc.
NeuroSense Therapeutics Ltd.
Promega Corporation
PureTech Health plc
ReNeuron Group plc
RION
Sienna Cancer Diagnostics Ltd
System Biosciences, LLC

Table Information

Report Attribute	Details
No. of Pages	196
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 265.76 Million
Forecasted Market Value ( USD ) by 2032	$ 746.33 Million
Compound Annual Growth Rate	19.1%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3400EUR$3,939USD£2,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3668EUR$4,249USD£3,178GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4971EUR$5,759USD£4,307GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6016EUR$6,969USD£5,212GBP

Market Snapshot: Exosome Diagnostics & Therapeutics Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact and Supply Chain Considerations

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Exosome Research Market - Global Forecast 2026-2032

Medicinal Exosomes Market - Global Forecast 2025-2030

Exosome Diagnostic and Therapeutic Market Outlook 2025-2034: Market Share, and Growth Analysis

Exosome Diagnostic and Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030